Biodesix Secures $17,756,512 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6481ed84-ce3e-4912-869d-b1b037e58253 - Date
2/16/2016 - Company Name
Biodesix - Mailing Address
2970 Wilderness Place Boulder, CO 80301 USA - Company Description
Biodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease. - Website
http://www.biodesix.com - Transaction Type
Venture Equity - Transaction Amount
$17,756,512 - Transaction Round
Undisclosed - Proceeds Purposes
Offer and sale of Series F Preferred Stock, conversion of Convertible Promissory Notes and offer and sale of contingent value rights relating to revenue from one of the Issuer’s products. 24 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
